Self-Adjusting Tinnitus Device: Compliance and Satisfaction

Bimodal neuromodulation, a treatment that pairs sound with mild tongue stimulation, has shown it can reduce tinnitus severity in clinical trials. But its practical implementation has faced a problem: the need for specialized, in-person clinical visits to fit and adjust the treatment device can be a significant barrier to access. A new study led by Grace Conchas, Yezihalem Mesfin, and Yuan He tested whether simplifying this process could maintain the treatment’s effectiveness. Their findings, published in *Frontiers in Audiology and Otology*, indicate that using standardized device settings and virtual follow-up sessions does not compromise outcomes, opening a path to more accessible care.

## A Simplified Treatment Protocol Tested for Accessibility

The research focused on a modified version of the Lenire bimodal neuromodulation device. Traditionally, such treatments require an audiologist to personalize the sound stimulation based on a patient’s individual hearing test (audiogram). Patients also typically need to return to a clinic for in-person follow-up sessions. For many, especially those in remote areas or without a local tinnitus specialist, these requirements can make treatment impossible.

This study removed those two major hurdles. First, clinicians set the device to standard, non-personalized audio settings for all participants, who could then make comfort-based adjustments themselves. Second, all follow-up support was conducted virtually, eliminating the need for travel to a clinic. The primary goal was to see if this simplified, more accessible protocol could still deliver the positive results seen in more complex clinical trials.

## High Compliance and Positive Outcomes After 12 Weeks

The researchers assessed 55 adults with chronic, bothersome tinnitus over a 12-week treatment period. They tracked how consistently participants used the device (compliance), how satisfied they were with it, and—most importantly—changes in their tinnitus severity using validated questionnaires like the Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI).

The results were clear. Compliance and satisfaction ratings stayed high, matching levels from previous studies that used the traditional, in-person fitting model. The clinical outcomes were also positive. The study reports that “many participants had changes that met the level of minimal clinically important difference on tinnitus severity questionnaires.” This means the reduction in tinnitus burden was meaningful from a patient’s perspective, not just a minor statistical change.

## Broader Access Without Sacrificing Results

The most significant finding is that the therapeutic effect did not diminish despite the simplified approach. The paper states directly: “The positive therapeutic outcomes of the study did not differ from previous reports using bimodal neuromodulation for tinnitus, despite simplifying the fitting process… and use of virtual follow-up sessions.”

This has direct practical implications. It suggests that effective tinnitus treatment does not always require highly specialized, in-person audiological fine-tuning for every patient. A more general approach with proper patient guidance can work. It also validates telehealth as a viable model for supporting patients through a neuromodulation treatment plan. For patients, this could mean faster access to care, lower costs, and the ability to receive support from experts regardless of geographic location. You can read more about the challenges and successes of managing tinnitus in different clinical settings in our article on Audiologist Tinnitus Management Outcomes in Singapore.

## What This Means for the Future of Tinnitus Care

This study, registered at ClinicalTrials.gov under identifier NCT05518682, points toward a more scalable future for certain tinnitus therapies. By decoupling treatment efficacy from rigid, clinic-bound procedures, it becomes possible to reach a larger population. The authors conclude that “these findings open up opportunities for broader accessibility and scalability of treatment options, such as bimodal neuromodulation, for tinnitus patients.”

This shift towards accessible, patient-centered models is relevant across hearing health. Just as personalized cognitive patterns are found to influence conditions like misophonia, the personal context of a patient’s life—their location, schedule, and access to specialists—fundamentally impacts their ability to receive care. Furthermore, the success of virtual follow-up aligns with growing evidence that remote care is effective, as discussed in our related piece on Tinnitus Treatment Compliance and Virtual Visits.

The research by Conchas, Mesfin, and He provides a pragmatic blueprint. It shows that for bimodal neuromodulation, reducing complexity and leveraging telehealth can maintain treatment integrity while directly addressing the real-world barriers that keep many people from finding relief.

**Source:** Conchas, G., Mesfin, Y., & He, Y. (2026). Usability assessment of a modified bimodal neuromodulation protocol for tinnitus with simplified fitting and virtual follow-up. *Frontiers in Audiology and Otology*, 5. DOI: 10.3389/fauot.2026.1789957.